Abstract:
Disclosed herein is a method of generating a coded data packet in dependence on a plurality of source data packets, the method comprising: determining a plurality of data packets, for generating a coded data packet, from a plurality of source data packets for encoding, wherein each of the plurality of source data packets for encoding comprises the same number of bits; generating a multiplied data packet in dependence on one or more multiplication operations between a multiplication value and bits of one of the determined data packets; and generating a coded data packet in dependence on a combination of the multiplied data packet and one or more of the other of said plurality of determined data packets that have not been multiplied; wherein the one or more multiplication operations are performed as operations in the finite field GF(p); p is greater than 2; the multiplication value is an element of the finite field GF(p); the multiplication value is not 0 or 1; and the combination of data packets is performed by bitwise XOR operations. Advantageously, the coding scheme can be almost as computationally efficient as GF(2) and the likelihood of obtained coded data packets being linearly independent is greatly increased.
Abstract:
Disclosed herein is a method of generating an encoded data packet over GF(2). The method comprises determining 303 a plurality of data packets in dependence on a Latin rectangle, wherein the plurality of data packets have equal length; and generating 305 an encoded data packet by bitwise XORing the determined plurality of data packets. The efficiency of encoding, decoding, and transmission over a network of data packets are all improved, as well as the security properties of the transmitted information.
Abstract:
An oligouronate is used in the treatment or prevention of cancer as an anticancer agent. The oligouronate is effective against cancer itself, and as a drug delivery tool which improves or promotes the delivery of another anticancer agent, such as a chemotherapy drug or immunotherapeutic agent. Thus, the oligouronate is used in cancer prevention or treatment alone or in combination with one or more other anticancer agents.
Abstract:
A wave energy convertor for extracting energy from ocean waves. The wave energy convertor may include a buoy arranged to oscillate relative to a reference point about an equilibrium position and a negative spring device connected between the buoy and the reference point, wherein the negative spring device is for applying a positive force in the direction of displacement when the buoy moves away from the equilibrium position.
Abstract:
The present invention provides an agent, or a composition containing an agent, for use in treating or preventing a bacterial infection in a subject, wherein said agent comprises: (i) an oligopeptidic compound comprising a PCNA interacting motif and a domain that facilitates the cellular uptake of said compound, wherein the PCNA interacting motif is X1X2X3X4X5 (SEQ ID NO: 1) and wherein: X1 is a basic amino acid; X2 is an aromatic amino acid; X3 is an uncharged amino acid other than an aromatic amino acid, Glycine (G) and Proline (P); X4 is any amino acid other than Proline (P), an acidic amino acid or an aromatic amino acid; and X5 is a basic amino acid or Proline (P); or (ii) a nucleic acid molecule comprising a sequence encoding the oligopeptidic compound of (i). In certain aspects the agent and compositions of the invention may be used as single agents. In other aspects of the invention agents and compositions of the invention may be used in conjunction with one or more additional active agents, such as antibiotics.
Abstract:
A photovoltaic device comprising at least one nanowire structure fixed to a substrate, wherein each of the at least one nanowire structures comprise: a heavily doped p-type core having a proximal end fixed to the substrate and a distal end extending away from the substrate; and a n-type shell around the p-type core.
Abstract:
A method of repairing a steel reinforced concrete structure (100) affected by chloride induced corrosion, comprising: subjecting the reinforced concrete structure (100) to an electrochemical treatment so as to enrich material (102, 120, 140) embedding the steel reinforcement (110) with chlorides originating from corrosion pits (112) in the steel reinforcement; and replacing the material (102, 120, 140) embedding the steel reinforcement (110), which has been enriched with chlorides during the electrochemical treatment, with a repair material (124) that is relatively poor in chlorides.
Abstract:
A method of locating a drilling apparatus and/or a borehole in a subterranean region. The method may include the steps of transmitting seismic waves into the subterranean region during a subterranean drilling operation, the seismic waves being transmitted from a location remote from the drilling apparatus, detecting a seismic response from the drilling apparatus or borehole, and comparing the detected response with predetermined seismic survey data of the subterranean region to determine the location of the apparatus or borehole.
Abstract:
A neuroinhibitory substance for use in a method for treating or preventing headache comprising injecting a neuroinhibitory substance such as botulinium toxin in close proximity to the sphenopalatine ganglion or otic ganglion wherein an injection device comprising said neuroinhibitory substance is brought into close proximity to the sphenopalatine ganglion or otic ganglion by inserting said injection device into the patient transnasally or infrazygomatically and the neuroinhibitory substance injected in close proximity to the SPG or OG.
Abstract:
The present application provides an optical system. The optical system includes a fiber amplifier with an optically active doped fiber, a source of seed pulses, and a pump source. The doped fiber is doped with one or more active element(s) selected such that the seed pulses are amplified in intensity. The doped fiber has a negative (anomalous) group velocity dispersion in the region from the wavelength of the seed pulses to a threshold wavelength at which the magnitude of the optical loss of the doped fiber is greater than a gain due to stimulated Raman scattering.